Texas Workplace Drug Testing: The Legal Framework

Under Texas law, private employers have broad discretion to adopt drug and alcohol testing policies for their workers. The Texas Workforce Commission (TWC) is explicit on this point: under Texas and federal laws, there is almost no limitation at all on the right of private employers to adopt drug and alcohol testing policies. Texas has no statewide statute that mandates specific drug testing procedures for most private employers, and no state law that restricts the circumstances under which a private employer may test.

That means Texas employers are largely free to design drug testing programs that match their workforce, industry, and operational needs. Pre-employment testing, random testing, post-accident testing, reasonable-suspicion testing, and return-to-duty testing are all permissible under Texas law for private employers. An employer may test some job classifications and not others. An employer may adopt a zero-tolerance policy or may set cutoff levels that define what constitutes a positive result. All of these decisions are left to the employer — provided they are reflected in a clear written policy.

The Written Policy Requirement

Texas law does not require most private employers to have a drug testing policy. But if an employer tests — and wants to use a positive result to discharge an employee and successfully defend an unemployment claim at TWC — that employer needs a written policy that meets specific documentation standards.

According to the TWC's employer guidance on drug testing, a basic written drug testing policy must address at minimum: what constitutes a violation, which employees are covered, and what disciplinary measures will result from violations. The policy should be given to all employees in writing, and each employee should sign a written acknowledgment of receipt. Employers who fail to present this documentation when responding to a TWC unemployment claim will lose the UI claim.

The on-site rapid drug test cup — whether a CLIA-waived urine cup or a saliva drug test kit — provides the initial presumptive screening result. That result is not a GC/MS confirmation. For any positive result that will be used as the basis for an adverse employment action at TWC, the employer must have the initial screen confirmed by a certified laboratory using GC/MS before discharging the employee and defending a UI claim.

Authorized Testing Occasions in Texas

Texas private employers may test under any of the following circumstances, provided the written policy covers them:

Choosing the Right Testing Method for Your Texas Workplace

Texas employers have several testing options depending on their workforce, testing environment, and program objectives. The two most common point-of-care formats are urine drug testing and oral fluid saliva testing — and the decision between them has real operational consequences. Employers deciding between formats should read our guide to 10-panel drug tests for Texas employers, which compares detection windows, collection logistics, tampering risk, and best-fit use cases for each format.

Urine drug testing remains the most widely used format for Texas workplace programs. Urine specimens provide a longer detection window — typically two to seven or more days for most substances — making them well-suited for pre-employment and routine compliance screening. CLIA-waived urine drug test cups can be administered on-site by trained non-laboratory staff, generate results in five minutes, and are available in configurations from 5 panels through 18 panels.

Oral fluid saliva testing offers a shorter detection window — typically the most recent 24 to 48 hours — making it the preferred format for reasonable-suspicion and post-accident testing where the question is whether someone is currently impaired rather than whether they used a substance a week ago. For employers in manufacturing, oil and gas, and safety-sensitive industries, saliva drug testing in Texas has grown as a complement to — rather than a replacement for — urine-based programs.

Panel Size: What Texas Employers Should Screen For

The number of substances included in a testing panel is one of the most consequential purchasing decisions in a Texas drug testing program. A 5-panel test covers the five substances in the SAMHSA federal workplace testing panel — amphetamines, cocaine, marijuana, opiates, and phencyclidine. A 10-panel or 12-panel test expands that coverage to include benzodiazepines, barbiturates, methadone, oxycodone, buprenorphine, and other prescription drug classes that account for a significant share of workplace substance use in Texas today.

Fentanyl requires specific attention. Standard opiate (OPI) panels do not detect fentanyl — detecting it requires a dedicated FTY analyte. Given the prevalence of fentanyl contamination in the Texas illicit drug supply, employers in industries with safety-sensitive roles should evaluate whether their current panel configuration addresses fentanyl explicitly. SAFElife urine cups with dedicated fentanyl detection are available in CLIA-waived and Forensic Use configurations.

Marijuana and THC Testing in Texas in 2026

Texas has not legalized recreational marijuana as of 2026. The Compassionate Use Program (CUP) permits limited medical cannabis use for qualifying conditions, but the program's scope remains narrow compared to states with full medical marijuana programs. Texas private employers are not required to accommodate medical cannabis users, and a positive THC result remains a legally defensible basis for adverse employment action under a compliant written policy.

Marijuana policies deserve particular attention as state laws and workplace policies continue to evolve nationally. Some Texas employers — particularly those operating in multiple states or recruiting from cannabis-legal markets — are evaluating non-THC drug testing panels that remove marijuana from the screen entirely while continuing to test for cocaine, opioids, amphetamines, and other workplace safety substances. This approach is not required in Texas but reflects a growing pragmatic trend among high-volume hiring operations.

DOT Drug Testing in Texas

Texas employers with DOT-regulated employees — long-haul truck drivers, pipeline workers, transit operators, aviation maintenance workers, and other safety-sensitive transportation roles — operate under a separate federal testing framework that is not optional and not subject to customization. DOT drug testing under 49 C.F.R. Part 40 requires urine testing administered through DOT-certified collection sites and certified laboratories, and specifies the exact five substances that must be screened. Employers subject to DOT requirements cannot substitute on-site rapid testing for DOT-mandated testing, though they may supplement DOT testing with their own non-DOT program for non-regulated employees.

Confidentiality and Record-Keeping

Drug test results are confidential medical records under both Texas law and the federal ADA. The TWC guidance is explicit: test results must be maintained in a separate, confidential medical file. Employers should use a signed consent form that allows the testing lab to release results to the employer and allows both parties to release results to TWC or to courts and agencies handling claims arising from the test. Without that consent, HIPAA may complicate the employer's ability to obtain results from the lab.

Drug Testing Supplies for Texas Employers

DrugScreens.com ships CLIA-waived urine drug test cups, oral fluid saliva drug test kits, dip cards, and specialty panels to Texas employers statewide — Dallas, Houston, San Antonio, Austin, Fort Worth, El Paso, and beyond. Bulk pricing, same-day shipping on qualifying orders, and wholesale rates for staffing agencies, construction operators, and HR departments running high-volume Texas programs.

This content is provided for general informational purposes only and does not constitute legal advice. Any employer or organization considering changes to its workplace or in-house drug screening policies should consult with qualified legal counsel and applicable regulatory authorities before implementing, modifying, or discontinuing any testing program or related procedures.